Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 5
2003 8
2004 12
2005 6
2006 21
2007 18
2008 12
2009 10
2010 10
2011 7
2012 6
2013 6
2014 4
2015 9
2016 7
2017 9
2018 2
2019 4
2020 11
2021 2
2022 3
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

163 results
Results by year

Citations

3 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Cardiovascular effects and safety of (non-aspirin) NSAIDs.
Schjerning AM, McGettigan P, Gislason G. Schjerning AM, et al. Nat Rev Cardiol. 2020 Sep;17(9):574-584. doi: 10.1038/s41569-020-0366-z. Epub 2020 Apr 22. Nat Rev Cardiol. 2020. PMID: 32322101 Review.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective, widely used analgesics. ...Selective cyclooxygenase 2 (COX2) inhibitors (also known as coxibs) have been associated with the greatest risk of adverse vascular effects but concern also …
Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective, widely used analgesics. ...Selective cyclooxygenase …
Non-steroidal anti-inflammatory drugs (NSAIDs), pain and aging: Adjusting prescription to patient features.
Ribeiro H, Rodrigues I, Napoleão L, Lira L, Marques D, Veríssimo M, Andrade JP, Dourado M. Ribeiro H, et al. Biomed Pharmacother. 2022 Jun;150:112958. doi: 10.1016/j.biopha.2022.112958. Epub 2022 Apr 19. Biomed Pharmacother. 2022. PMID: 35453005 Free article. Review.
From 828 articles identified, only eight met the inclusion criteria. Selective COX-2 inhibitors are associated with higher cardiovascular risk, while non-selective COX inhibitors are associated with higher gastrointestinal risk. ...Patien …
From 828 articles identified, only eight met the inclusion criteria. Selective COX-2 inhibitors are associated with higher cardiov
[Cardiovascular risk of non-steroidal anti-inflammatory drugs].
Prozzi GR, Cañás M, Urtasun MA, Buschiazzo HO, Dorati CM, Mordujovich-Buschiazzo P. Prozzi GR, et al. Medicina (B Aires). 2018;78(5):349-355. Medicina (B Aires). 2018. PMID: 30285927 Free article. Review. Spanish.
Non-steroidal anti-inflammatories (NSAIDs) are among the most commonly used drugs in clinical practice. They block cyclooxygenases (COX) enzymes, but the degree of inhibition of COX-1 and COX-2 varies between them. In general, NSAIDs are classif
Non-steroidal anti-inflammatories (NSAIDs) are among the most commonly used drugs in clinical practice. They blo
Non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and cardiovascular risk.
Fanelli A, Romualdi P, Vigano' R, Lora Aprile P, Gensini G, Fanelli G. Fanelli A, et al. Acta Biomed. 2013 Jun 1;84(1):5-11. Acta Biomed. 2013. PMID: 24189757 Review.
Nevertheless, the cardiovascular risk related to the use of NSAIDs is not only due to the COX-2 selectivity. ...The aim of this review is to analyse the mechanisms behind the cardiovascular risk of different NSAIDs....
Nevertheless, the cardiovascular risk related to the use of NSAIDs is not only due to the COX-2 selectivity. ...The aim …
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS. Chen YF, et al. Health Technol Assess. 2008 Apr;12(11):1-278, iii. doi: 10.3310/hta12110. Health Technol Assess. 2008. PMID: 18405470 Free article. Review.
OBJECTIVES: To review the clinical effectiveness and cost-effectiveness of cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drugs (NSAIDs) (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxi …
OBJECTIVES: To review the clinical effectiveness and cost-effectiveness of cyclooxygenase-2 (COX-2) selective non-steroidal
Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
Cooper C, Chapurlat R, Al-Daghri N, Herrero-Beaumont G, Bruyère O, Rannou F, Roth R, Uebelhart D, Reginster JY. Cooper C, et al. Drugs Aging. 2019 Apr;36(Suppl 1):15-24. doi: 10.1007/s40266-019-00660-1. Drugs Aging. 2019. PMID: 31073921 Free PMC article. Review.
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely recommended and prescribed to treat pain in osteoarthritis. ...Cardiovascular toxicity is associated with all NSAIDs to some extent and the degree of risk appears to
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely recommended and prescribed to treat pain in ost
Guidance on the management of pain in older people.
Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, Knaggs R, Martin D, Sampson L, Schofield P; British Geriatric Society. Abdulla A, et al. Age Ageing. 2013 Mar;42 Suppl 1:i1-57. doi: 10.1093/ageing/afs200. Age Ageing. 2013. PMID: 23420266 Review.
It is, however, important that the maximum daily dose (4 g/24 h) is not exceeded. Non-selective non-steroidal anti-inflammatory drugs (NSAIDs) should be used with caution in older people after other safer treatments have not provid …
It is, however, important that the maximum daily dose (4 g/24 h) is not exceeded. Non-selective non-steroidal
Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.
Szeto CC, Sugano K, Wang JG, Fujimoto K, Whittle S, Modi GK, Chen CH, Park JB, Tam LS, Vareesangthip K, Tsoi KKF, Chan FKL. Szeto CC, et al. Gut. 2020 Apr;69(4):617-629. doi: 10.1136/gutjnl-2019-319300. Epub 2020 Jan 14. Gut. 2020. PMID: 31937550
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed medications, but they are associated with a number of serious adverse effects, including hypertension, cardiovascular disease, kidne …
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed medica …
Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis.
Cheng BR, Chen JQ, Zhang XW, Gao QY, Li WH, Yan LJ, Zhang YQ, Wu CJ, Xing JL, Liu JP. Cheng BR, et al. PLoS One. 2021 Dec 21;16(12):e0261239. doi: 10.1371/journal.pone.0261239. eCollection 2021. PLoS One. 2021. PMID: 34932581 Free PMC article.
OBJECTIVE: To assess the cardiovascular safety of celecoxib compared to non-selective non-steroid anti-inflammatory drugs or placebo. ...There was no significant difference between celecoxib and non-selective non-ster …
OBJECTIVE: To assess the cardiovascular safety of celecoxib compared to non-selective non-steroid anti- …
Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
Gunter BR, Butler KA, Wallace RL, Smith SM, Harirforoosh S. Gunter BR, et al. J Clin Pharm Ther. 2017 Feb;42(1):27-38. doi: 10.1111/jcpt.12484. Epub 2016 Dec 26. J Clin Pharm Ther. 2017. PMID: 28019014 Review.
WHAT IS KNOWN AND OBJECTIVE: Although non-steroidal anti-inflammatory drugs (NSAIDs) have been studied in randomized, controlled trials and meta-analyses in an effort to determine their cardiovascular (CV) risks, no consensus has been rea …
WHAT IS KNOWN AND OBJECTIVE: Although non-steroidal anti-inflammatory drugs (NSAIDs) have been studied in …
163 results